On Thursday, Bristol-Myers Squibb Co (NYSE:BMY)’s shares inclined 0.14% to $69.38.
Alexandria Real Estate Equities, Inc. (ARE), the largest and leading REIT uniquely focused on collaborative science campuses in urban innovation clusters, declared recently that Bristol-Myers Squibb (BMY), a global biopharmaceutical company, will establish a state-of-the-art research and development center at the Alexandria Center® at Kendall Square (ACKS) in the heart of the Cambridge Kendall Square innovation cluster. As the anchor tenant in Alexandria’s newest ground-up development at 100 Binney Street, Bristol-Myers Squibb will lease 208,000 rentable square feet (RSF) in a world-class, highly sustainable office/laboratory facility that has a total of 431,500 RSF. The project will start construction in July 2015 and is predictable to be delivered in the fourth quarter of 2017.
The decision by Bristol-Myers Squibb to locate its state-of-the-art research facility in the Cambridge Kendall Square innovation cluster affirms Alexandria Center at Kendall Square’s reputation as one of the world’s most desirable locations for life science recruitment, innovation, and collaboration.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Carnival Corp (NYSE:CCL)’s shares gained 0.71% to $52.21.
Carnival Corporation & plc (CCL) has declared that it has raised its quarterly dividend to $0.30 per share.
The company’s board of directors approved a record date for the quarterly dividend of August 21, 2015, and a payment date of September 11, 2015.
Holders of Carnival Corporation common stock and Carnival plc ADSs will receive the dividend payable in U.S. dollars. The dividend for Carnival plc ordinary shares will be payable in U.S. dollars or sterling. In the absence of instructions or elections to the contrary, holders of Carnival plc ordinary shares will automatically receive the dividend in sterling.
Dividends payable in sterling will be converted from U.S. dollars at the exchange rate quoted by the Bank of England in London at 12 noon on September 1, 2015. Holders of Carnival plc ordinary shares wishing to receive their dividend in U.S. dollars or take part in the Carnival plc Dividend Reinvestment Plan must elect to do so by August 21, 2015.
Carnival Corporation operates as a cruise company worldwide. It provides vacations to various cruise destinations. The company offers cruise services under the Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn brand names in North America; and AIDA Cruises, Costa Cruises, Cunard, and P&O Cruises names in Europe, Australia, and Asia. It operates 100 cruise ships.
At the end of Thursday’s trade, Abbott Laboratories (NYSE:ABT)‘s shares surged 0.93% to $49.77.
Abbott (ABT) will declare its second-quarter 2015 financial results on Wednesday, July 22, 2015, before the market opens.
The declarement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott’s Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be accessible after 11 a.m. Central time.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
